HomeCompareTOS vs JNJ

TOS vs JNJ: Dividend Comparison 2026

TOS yields 8.14% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TOS wins by $14.3K in total portfolio value
10 years
TOS
TOS
● Live price
8.14%
Share price
$24.57
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.3K
Annual income
$1,362.18
Full TOS calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TOS vs JNJ

📍 TOS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTOSJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TOS + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TOS pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TOS
Annual income on $10K today (after 15% tax)
$691.90/yr
After 10yr DRIP, annual income (after tax)
$1,157.85/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, TOS beats the other by $454.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TOS + JNJ for your $10,000?

TOS: 50%JNJ: 50%
100% JNJ50/50100% TOS
Portfolio after 10yr
$27.2K
Annual income
$1,094.98/yr
Blended yield
4.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TOS
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TOS buys
0
JNJ buys
0
No recent congressional trades found for TOS or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTOSJNJ
Forward yield8.14%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$34.3K$20.0K
Annual income after 10y$1,362.18$827.78
Total dividends collected$10.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TOS vs JNJ ($10,000, DRIP)

YearTOS PortfolioTOS Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,514$814.00$10,676$355.77+$838.00TOS
2$13,196$875.93$11,407$389.39+$1.8KTOS
3$15,058$938.20$12,198$426.53+$2.9KTOS
4$17,112$1,000.54$13,056$467.62+$4.1KTOS
5$19,373$1,062.68$13,987$513.12+$5.4KTOS
6$21,853$1,124.35$14,998$563.56+$6.9KTOS
7$24,568$1,185.34$16,098$619.52+$8.5KTOS
8$27,534$1,245.42$17,295$681.69+$10.2KTOS
9$30,765$1,304.43$18,599$750.82+$12.2KTOS
10$34,281$1,362.18$20,022$827.78+$14.3KTOS

TOS vs JNJ: Complete Analysis 2026

TOSStock

TOS seeks total return by investing in US equity securities across all market caps. The fund may invest in equities, other ETFs (including affiliated funds), and derivatives such as options, swaps, futures, and structured notes. Selection combines bottom-up fundamental research on individual securities with top-down portfolio analysis. The fund also may employ hedging strategies using option contracts, swaps, and other derivatives, hedging specific securities or broader market exposures through indices or ETFs. Certain derivatives can have a leverage-like effect. The fund may also invest in cash, cash equivalents, or money market instruments, and may hold an affiliated ETF focused on capital appreciation and low volatility during downturns. As an actively managed ETF, the fund manager has full discretion to adjust the portfolio at any time.

Full TOS Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TOS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TOS vs SCHDTOS vs JEPITOS vs OTOS vs KOTOS vs MAINTOS vs ABBVTOS vs MRKTOS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.